Physician profile
Patrick Field
NPI 1306208996
$4,214.41
in general payments reported to CMS, 2019-2025
12 companies · $3,953 in 2025
The $3,953 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $164 · 2023: $34.96 · 2024: $61.95 · 2025: $3,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Travel and Lodging: $1,144 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,746.59 |
| Travel and Lodging | $1,144.44 |
| Education | $159.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,261.91 | 2025 | General - Therapies, Watchman Flx, Farapulse |
| Cardiva Medical, INC. | $215.22 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $187.92 | 2022-2025 | Impella |
| Medtronic, INC. | $159.25 | 2025 | |
| Philips North America LLC | $110.67 | 2025 | Lm Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.16 | 2022-2025 | Lifevest |
| Pfizer INC. | $43.54 | 2025 | |
| Abbott Laboratories | $37.89 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Impulse Dynamics (USA) INC. | $34.96 | 2023 | Optimizer |
| Shockwave Medical, INC | $31.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.33 | 2025 | Jardiance |
| Terumo Medical Corporation | $21.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.